000 | 01552 a2200421 4500 | ||
---|---|---|---|
005 | 20250518033308.0 | ||
264 | 0 | _c20190903 | |
008 | 201909s 0 0 eng d | ||
022 | _a1950-6007 | ||
024 | 7 |
_a10.1016/j.biopha.2019.108725 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAl-Qahtani, Alanod D | |
245 | 0 | 0 |
_aProduction of "biobetter" variants of glucarpidase with enhanced enzyme activity. _h[electronic resource] |
260 |
_bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _cApr 2019 |
||
300 |
_a108725 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
650 | 0 | 4 | _aCloning, Molecular |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aEnzyme Stability |
650 | 0 | 4 |
_aEnzyme Therapy _xmethods |
650 | 0 | 4 |
_aMethotrexate _xadverse effects |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aPoint Mutation |
650 | 0 | 4 |
_aProdrugs _xadministration & dosage |
650 | 0 | 4 |
_aPseudomonas putida _xgenetics |
650 | 0 | 4 |
_aRecombinant Proteins _xgenetics |
650 | 0 | 4 |
_agamma-Glutamyl Hydrolase _xgenetics |
700 | 1 | _aBashraheel, Sara S | |
700 | 1 | _aRashidi, Fatma B | |
700 | 1 | _aO'Connor, C David | |
700 | 1 | _aRomero, Atilio Reyes | |
700 | 1 | _aDomling, Alexander | |
700 | 1 | _aGoda, Sayed K | |
773 | 0 |
_tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie _gvol. 112 _gp. 108725 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biopha.2019.108725 _zAvailable from publisher's website |
999 |
_c29574392 _d29574392 |